交界性卵巢肿瘤的诊治进展

交界性卵巢肿瘤（BOTs），约占所有卵巢上皮性肿瘤的10％～15％，许多研究结果表明其有着比较好的预后。由于交界性卵巢肿瘤病理学及临床特性较独特，在诊断和治疗上具有不同于卵巢癌的特点。该肿瘤常发生于生育年龄妇女．诊断时大多数处于早期。手术切除是治疗交界性卵巢肿瘤的主要方法，由于诊断常发生在术中，缺乏确切的术前诊断标准，而且大多数患者都要求保留生育能力，因此交界性卵巢肿瘤的早期诊断、保守性治疗及术后化疗都存在着争议。

Research Progress of Diagnosis and Treatment for Borderline Ovarian Tumors

Bordedine ovarian tumor （BOT） accounts for 10%-15% of all ovarian epithelial tumors, many studies have indicated that they have excellent long-term prognosis. Because of their unique pathological and clinical characteristics, the diagnosis and management of this disease is different from those of ovarian cancer. Clinically, BOT occurrs in women in the reproduction age group and majority are in early stage at diagnosis. Surgical removal of BOT is an important management of BOT. Due to the absence of specific preoperative criteria, diagnosis is often made during surgery, and a number of young woman patients want to preserve their child bearing potential. Thus, a lot of debate exists on the early diagnosis, conservative surgery, postoperative adjuvant therapy and fertility outcome.